Markets:

Overview

News

Currencies

International

Treasuries

Vanda Pharmaceuticals Inc. - Common Stock (NQ:VNDA)

4.490 -0.090 (-1.97%)

Delayed Quote Updated: 12:39 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vanda Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Earnings Scheduled For February 23, 2022 ↗

February 23, 2022

Companies Reporting Before The Bell • Sapiens Intl Corp (NASDAQ:SPNS) is likely to report earnings for its fourth quarter. • Plymouth Industrial REIT (NYSE:PLYM)...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

50 Biggest Movers From Friday ↗

February 07, 2022

Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 04, 2022

Gainers Quidel (NASDAQ:QDEL) shares incre...

Via Benzinga

Earnings Scheduled For July 28, 2021 ↗

July 28, 2021

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.55 per share on revenue of $7.90 billion. • United...

Via Benzinga

Mid-Afternoon Market Update: Dow Turns Positive; Snap Shares Climb Following Upbeat Results ↗

February 04, 2022

The Dow Jones turned higher later in the session on Friday following upbeat earnings from Amazon.com, Inc. (NASDAQ: AMZN) and strong payrolls report for January.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 04, 2022

Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is...

Via Benzinga

Tech Earnings Prop Up Nasdaq as Bond Yields Rise ↗

February 04, 2022

The Dow Jones Industrial Average is down 260 points midday, as a spike in the 10-year Treasury yield puts pressure on the market.

Via Talk Markets

Mid-Day Market Update: Dow Drops 100 Points; U.S. Nonfarm Payrolls Top Estimates ↗

February 04, 2022

US stocks traded mixed on Friday after Amazon.com, Inc. (NASDAQ: AMZN) reported better-than-expected earnings for its fourth quarter.

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

February 04, 2022

Gainers Snap Inc. (NYSE: SNAP) shares climbed 53.3% to $37.51 after the company reported better-than-expected Q4 EPS and sales results and issued Q1 sales guidance above...

Via Benzinga

Mid-Morning Market Update: Nasdaq Jumps 100 Points As Amazon Profit Tops Estimates ↗

February 04, 2022

US stocks opened on a mixed note on Friday after Amazon.com, Inc. (NASDAQ: AMZN) reported better-than-expected earnings for its fourth quarter.

Via Benzinga

Why Are Vanda Pharma Shares Plunging Today? ↗

February 04, 2022

Vanda Pharmaceuticals Inc (NASDAQ: VNDA) shares are plunging after the company announced Phase 3 trial data of tradipitant in treating the symptoms of gastroparesis.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

February 04, 2022

Gainers Calyxt (NASDAQ:CLXT) shares rose 12.4% to $1.63 during Friday's pre-market session. The company's market cap stands at $62.7 million. Better Therapeutics (...

Via Benzinga

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus ↗

December 26, 2021

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key...

Via Talk Markets

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year ↗

December 26, 2021

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating...

Via Benzinga

Vanda Pharmaceuticals Inc (VNDA) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

VNDA earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Vanda Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2021

Vanda Pharmaceuticals (NASDAQ:VNDA) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

81 Biggest Movers From Yesterday ↗

November 05, 2021

Gainers Evaxion Biotech A/S (NASDAQ: EVAX) shares jumped 95.1% to close at $12.68 on Thursday after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) jumped 79.8...

Via Benzinga

Earnings Scheduled For November 3, 2021 ↗

November 03, 2021

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....

Via Benzinga

Novavax Appoints New CFO Amid Inordinate Delay In COVID-19 Vaccine Authorization ↗

August 16, 2021

Novavax, Inc. (NASDAQ: NVAX) announced new hires to its executive team even as it is stymied by the delay in getting authorization for its COVID-19 vaccine in the U.S. What...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 03, 2021

Gainers Outlook Therapeutics (NASDAQ:OTLK) shares increased by 38.49% to $3.13 during Tuesday's pre-market session. The company's market cap stands at $543.3...

Via Benzinga

Vanda Pharmaceuticals Inc (VNDA) Q2 2021 Earnings Call Transcript ↗

July 29, 2021

VNDA earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Vanda Pharmaceuticals: Q2 Earnings Insights ↗

July 28, 2021

Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 6.25% year...

Via Benzinga

BridgeBio Pharma Stock Sees Rising Relative Strength; Still Shy Of Key Threshold ↗

July 01, 2021

In a welcome move, biotech BridgeBio Pharma stock saw its Relative Strength Rating rise from 70 to 73 on Thursday.

Via Investor's Business Daily

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

Translate Bio Stock Flashes Improved Technical Strength Rating; Triple-Digit Sales Growth ↗

June 28, 2021

Translate Bio shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

Stocks That Hit 52-Week Highs On Thursday ↗

July 01, 2021

This morning 158 companies set new 52-week highs. Intriguing Points: NVIDIA (NASDAQ:NVDA) was the largest firm on a market cap basis to set a new 52-week high. The...

Via Benzinga

Crispr Therapeutics Stock Sees Improved Relative Strength Rating ↗

June 25, 2021

Crispr Therapeutics stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 68 to 74.

Via Investor's Business Daily

The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗

July 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Vanda Pharmaceuticals Inc. - Common Stock (NQ:VNDA)

All News about Vanda Pharmaceuticals Inc. - Common Stock

Starting at /week.